Survival among hospital in-patients with troponin T elevation below levels defining myocardial infarction

QJM: An International Journal of Medicine

Volumn 98, Issue 4, 2005, Pages 275-282

  Cook, Gary ^a   Taylor, D ^a   France, M ^b   Burrows, G ^a   Manning, E ^c   Lyratzopoulos, G ^e   McElduff, P ^d   Lewis, P ^a   Martin, M ^a   Heller, R F ^d  

^a STOCKPORT NHS FOUNDATION TRUST   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e Norfolk Suffolk and Cambridgeshire Strategic Health Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; CREATININE; DRUG; TROPONIN T;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BIOASSAY; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STANDARDIZATION; STATISTICAL SIGNIFICANCE; SURVIVAL;

EID: 20144388942     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hci045     Document Type: Article

References (14)

1. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959-69.
2. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003; 49 1331-6.
3. James S, Armstrong P, Califf R, Simoons ML, Venge P, Wallentin L, et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 2003; 115:178-84.
4. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 1996; 93:1651-7.
5. Luscher MS, Thygesen K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia. Circulation 1997; 96 2578-85.
6. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 1996; 335: 1333-41.
7. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001; 38: 478-85.
8. Diagnostic testing emerging from the gloom? Bandolier 1999; 70:70-5.
9. Zarich SW, Bradley K, Mayall ID, Bernstein LH. Minor elevations in troponin T values enhance risk assessment in emergency department patients with suspected myocardial ischemia: analysis of novel troponin T cut-off values. Clin Chim Acta 2004; 343:223-9.
10. Solymoss BC, Bourassa MG, Fortier A, Theroux P. Evaluation and risk stratification of acute coronary syndromes using a low cut-off level of cardiac troponin T, combined with CK-MB mass determination. Clin Biochem 2004; 37:286-92.
11. Henrikson CA, Howell EE, Bush DE, Miles JS, Meininger GR, Friedlander T et al. Prognostic usefulness of marginal troponin T elevation. Am J Cardiol 2004; 93:275-9.
12. Fox KA, Birkhead J, Wilcox R, Knight C, Barth J. British Cardiac Society Working Group on the definition of myocardial infarction. Heart 2004; 90:603-9.
13. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R, Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45:1104-21.
14. Henriksen PA and Flapan AD. Hyper-troponinaemia - a laboratory result, not a clinical diagnosis. J R Coll Physicians Edinburgh 2004; 34:192-5.